Results, Reports and Publications
Latest Results
Clariant delivers resilient Q3 profitability in a continued challenging market environment
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
- Q3 2024 sales decreased by 1 % in local currency1 to CHF 991 million, with stable pricing and volume growth in Adsorbents & Additives and Care Chemicals offsetting lower Catalysts volumes
- Lucas Meyer Cosmetics delivered strong growth and 2 % of Group sales; integration well on track
- Q3 2024 EBITDA margin before exceptional items of 15.6 % versus 15.9 % in Q3 2023, reflecting lower sales partly offset by effective margin management
- Q3 2024 reported EBITDA margin of 14.0 % below 15.4 % in Q3 2023 due to lower Catalysts volumes and restructuring charges relating to corporate cost measures
- 9M 2024 sales decreased by 5 % in local currency to CHF 3.061 billion while the reported EBITDA margin improved to 15.6 % compared to 15.1 % in the prior year
- Outlook 2024: Profitability confirmed on slightly lower sales; medium-term targets confirmed
"Clariant delivered resilient profitability in the third quarter of 2024 despite a continued challenging environment. We achieved growth in our Adsorbents & Additives and Care Chemicals businesses while maintaining pricing discipline in all businesses. However, lower than expected Catalysts volumes impacted Group sales, EBITDA margin, and our full-year sales outlook. The integration of Lucas Meyer Cosmetics remains well on track, while the sale of the Podari plant assets and the downsizing of the bioethanol business are progressing with lower financial impact than originally anticipated. With continued progress in our performance improvement programs, we confirm our 2024 profitability guidance and reaffirm our medium-term targets." said Conrad Keijzer, Chief Executive Officer of Clariant.
1 All references to local currency growth, pricing, volumes, and scope exclude the impact from hyperinflation countries Argentina and Türkiye. All references to currency include a net impact from hyperinflation countries Argentina and Türkiye.
Read more
Results Center
Please use the Results Center to find Clariant’s financial results and associated documents as published in the last five years
Q1 Q2 Q3 Q4 Date 30 April 2024 30 July 2024 29 October 2024 28 February 2025 Quiet Period as of 11 April as of 10 July as of 9 October Media Release EN EN EN Analyst Presentation EN EN EN Webcast Replay Audio recording MP3 MP3 MP3 Transcript EN EN EN Financial Review / HY Report EN - XLS Annual Report
Q1 Q2 Q3 Q4 Date 5 May 2023 28 July 2023 30 October 2023 29 February 2024 Quiet Period as of 17 April as of 10 July as of 10 October as of 15 January Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript EN EN EN EN Financial Review / HY Report EN EN — XLS Annual Report EN
Q1 Q2 Q3 Q4 Date 15 June 2022 28 July 2022 27 October 2022 2 March 2023 Quiet Period as of 11 July as of 10 October as of 17 February Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript
EN Financial Review / HY Report EN EN Annual Report EN
Q1 Q2 Q3 Q4 Date 29 April 2021 29 July 2021 28 October 2021 19 May 2022 Quiet Period as of 19 April as of 12 July as of 18 October Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript
Financial Review / HY Report EN EN Annual Report EN
Conferences and Roadshows
Clariant's Management and Investor Relations Team regularly participates in Conferences and Roadshows. Below you can find an overview of the presentations provided at such events in the last two years.
For an overview of upcoming events, please refer to the Financial Calendar.
